logo
World's most premature baby defies all medical odds to reach 1st birthday

World's most premature baby defies all medical odds to reach 1st birthday

Fox News2 days ago
An Iowa family recently celebrated a major milestone for a very special baby.
Mollie and Randall Keen welcomed their son, Nash Keen, on July 5, 2024. He was born 133 days early, at just 21 weeks gestation.
Guinness World Records has officially recognized Nash as the world's most premature baby to survive.
Earlier this month, Nash — affectionately nicknamed "Nash Potato" — turned 1 year old, defying all odds.
When he was born at the University of Iowa Health Care Stead Family Children's Hospital, Nash weighed just 285 grams (10 ounces) at birth — less than a grapefruit — and measured 24 centimeters long, according to a press release from the hospital.
Two years before Nash's premature birth, the Keens lost a baby girl, McKinley, at 18 weeks gestation.
At that time, Mollie Keen was diagnosed with an incompetent cervix, which is when the lower part of the cervix begins to open (dilate) too early, typically in the second trimester, the release shared.
She also suffers from polycystic ovary syndrome (PCOS), a hormonal disorder that can cause fertility difficulties.
Six months after their loss, the Keens found out another baby was on the way.
"When we went to our local doctor's office for the 20-week scan for Nash, I just had some concerns about how I was feeling, so I asked them to look at me closer — which they normally don't do at that appointment — and they found I was already 2 centimeters dilated," Mollie Keen said.
A few days later, she began having contractions and was placed on bed rest.
"We were devastated," she said. "We thought we were going through the exact same thing — we thought we were going to lose this baby."
The medical team at Stead Family Children's Hospital's neonatal intensive care unit (NICU) provides life-saving care for babies born at 21 weeks gestation and later.
Fortunately, Mollie's care team was able to delay labor until just 10 hours after Nash surpassed the 21-week mark.
"We want what is best for patients, so we really try to convey that we do not know what the outcomes will be for these extremely premature births," said Malinda Schaefer, M.D., Ph.D., the high-risk obstetrician who delivered Nash.
"It is important for parents to understand most survival rates are low, and if babies do survive, they have a very high risk of long-term complications, even at 22 weeks."
The team quickly provided medicine to Nash to support his organ development and to reduce the risk of complications, according to the release.
"Sometimes babies born at 21 weeks are just too small for even our tiniest breathing tubes and intravenous lines," said neonatologist Amy Stanford, who treated Nash. "Our NICU team assessed Nash, and I was able to place a breathing tube. Once we had the breathing tube in, his heart rate stabilized and his oxygen levels were good."
Even so, Nash's chances were slim, as no baby that young had ever survived.
Before Nash's birth, the most premature baby to survive was Curtis Zy-Keith Means, born to Michelle Butler on July 5, 2020, at the University of Alabama at Birmingham Hospital, according to Guinness World Records. He was born at a gestational age of 21 weeks and 1 day, which was 132 days premature.
"We never want the parents to lose hope, but many of them are in an unreal situation, so we have to be very honest with them," said​ Patrick McNamara, M.D., division director of neonatology at Stead Family Children's Hospital.
"I would have told his parents, 'The chance is zero, but I hope I'm wrong, and we will do everything we can to help him.'"
"I want him to see his story as a source of strength."
Around the one-month mark, Stanford said, the team began to "breathe a little easier."
"While we knew Nash still had a long journey ahead, that was the point when we started to feel more confident that he had a real chance of going home."
"It was a subtle but powerful shift – from day-to-day survival to long-term hope."
Nash received ongoing care during his 198 days in the hospital, as the team monitored his heart function and brain health.
In addition to receiving many medications, he also underwent surgery for a perforated bowel, which has up to a 40% mortality rate.
"They were on top of it every step of the way. They really gave him a fighting chance," said Randall Keen. "They were really honest with us during the whole journey about what his chances looked like. They made sure we were well-informed and kept us involved in all the decision-making."
After more than six months in the hospital, Nash was finally able to go home in January 2025.
He will continue to be monitored for ongoing health issues, including a minor heart defect, and is currently being weaned from oxygen. Nash is still on a feeding tube and wears hearing aids.
Although he has had some developmental delays, Nash is getting stronger and more interactive with the help of ongoing therapy sessions, according to his mother.
Stanford shared her ultimate goal for Nash — "that by the time he's 5 years old when he goes to kindergarten, no one will know that he was born so early."
"Nash's remarkable outcome reflects the progress we've made by building on the experiences of those patients who came before him," she added.
For more Health articles, visit www.foxnews.com/health
Mollie Keen shared that she wants Nash to know how loved he is — and "how many people have cheered him on from the very beginning."
"I want him to grow up and be healthy, happy and confident in who he is. I want him to see his story as a source of strength."
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

Yahoo

time11 hours ago

  • Yahoo

SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results

NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

Yahoo

time11 hours ago

  • Yahoo

Sarepta shares rebound after shipments of gene therapy Elevidys resume in US

(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

Sweeping Problems Under The Rug By The Feds Doesn't Make Them Go Away
Sweeping Problems Under The Rug By The Feds Doesn't Make Them Go Away

Forbes

time11 hours ago

  • Forbes

Sweeping Problems Under The Rug By The Feds Doesn't Make Them Go Away

A man walks his dog past a homeless man sleeping under a message painted on a boarded up shop in San ... More Francisco, California on April, 1, 2020, during the novel coronavirus outbreak. - The US death toll from the coronavirus pandemic topped 5,000 late on April 1, according to a running tally from Johns Hopkins University. (Photo by Josh Edelson / AFP) (Photo by JOSH EDELSON/AFP via Getty Images) For decades, every administration, every Congress, put many things off for someone else to deal with. No one can get everything done all the time, that's understandable. But many current economic and social programs aren't a result of juggling what might be possible. Instead, they have become the ultimate attempt to kick every can down the road. That doesn't solve problems. It only hides them and allows them to grow and fester. One of the current examples is homelessness. Here is a statement out of the presidential executive order, Ending Crime And Disorder On America's Streets: 'The overwhelming majority of these individuals are addicted to drugs, have a mental health condition, or both. Nearly two-thirds of homeless individuals report having regularly used hard drugs like methamphetamines, cocaine, or opioids in their lifetimes. An equally large share of homeless individuals reported suffering from mental health conditions.' Homelessness is a problem in many parts of the country. And, yes, people on the streets are often troubled in one way or another. However, the entire executive order is a rhetorical setup, claiming that 'nearly two-thirds' of the individuals reporting having used 'hard drugs like methamphetamines, cocaine, or opioids in their lifetimes.' No source for the statistic that is then delivered to deemphasize that any such use might have been long before. And then a statement that an 'equally large share of homeless individuals reported suffering from mental health conditions.' No source, again, and no explanation of what mental health conditions mean. Broadly defined enough, like any amount of depression, anxiety, discomfort, and so on, it could include everyone in the country. Next, a combination of claiming that spending by the federal government and states has run tens of billions on failed programs 'that address homelessness but not its root causes.' After claiming that homeless people leave 'other citizens vulnerable to public safety threats' comes the statement, 'Shifting homeless individuals into long-term institutional settings for humane treatment through the appropriate use of civil commitment will restore public order.' After stating that previous spending never looked at root causes, presuming that the administration knows the root causes, the proffered solution is to lock people away. The message is to ignore the problem and put it out of sight. The point isn't really for safety, because most dangerous behavior in the country doesn't come from homeless people. It's for comfort and to pretend everything is fine. This has economic and social implications. Institutionalize where? Privately owned prisons where someone makes a lot of money from incarcerations? Hospitals that have been financially struggling but will even more now that Medicaid has been so thoroughly cut? Similar issues come in arguments over diversity, equity, and inclusion, or DEI. The administration wants it purged not only from websites and government discussions, but from corporations, universities, and anywhere else the term might appear. Again, the communication expressed by action is to strike any mention of the topic anywhere, to bury it from consciousness as though that makes issues go away. It never does. Other parts of life are no different. Corporations want to promote the use of the most recent forms of artificial intelligence. Traditionally, the argument executives would use is not that technology was about enabling job cuts, but to free people up to do more useful and interesting work. That mask has finally begun to slip as CEOs and their corporations boast of shrinking their workforces. Ultimately, this will lead to fewer people being employed, greater degrees of consumer financial struggle, and economic weakness. But, again, that all gets brushed under the carpet. No society can long stand with such undermining. So long as problems are ignored, they likely grow worse until there comes a point that they demand more resources than are available.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store